Translational Autoimmunity, Volume 2
Treatment of Autoimmune Diseases
Published on 10. January 2022
Book
Paperback/Softback
486 pages
978-0-12-824390-9 (ISBN)
Description
Translational Autoimmunity: Treatment of Autoimmune Diseases, Volume Two in the Translational Immunology series, focuses on advances in therapeutic modalities in autoimmune diseases. Efficacy and safety of not only the current biologic therapies, but also novel drug targets are discussed. Therapeutic targeting of B regulatory cells, T regulatory cells, as well as the immunomodulation effects of nanoparticles and organisms are also covered, along with our understanding and future challenges of prognostic significance of treatments in autoimmune diseases.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Illustrations
65 illustrations (50 in full color); Illustrations
Dimensions
Height: 236 mm
Width: 192 mm
Thickness: 24 mm
Weight
975 gr
ISBN-13
978-0-12-824390-9 (9780128243909)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
E-Book
01/2022
Academic Press
€155.00
Available for download
Person
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the founding President of the Universal Scientific Education and Research Network (USERN). Professor Rezaei has already been the Director of more than 55 research projects and has designed and participated in several international collaborative projects. Professor Rezaei is an editorial assistant or board member for more than 30 international journals. He has edited more than 35 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,000 scientific papers in the international journals.
Content
1. Introduction on therapeutic opportunities for autoimmunity
2. Innate lymphoid cells as therapeutic targets in autoimmune diseases
3. B regulatory cells in patients with autoimmune diseases: pathogenic significance, therapeutic potential
4. Regulatory T cells in autoimmunity and potential therapeutic targets
5. Application of IL-6 antagonists in autoimmune disorders
6. The search for monomer interaction-based alternative TNF? therapies
7. Generation of thymic cells from pluripotent stem cells for basic research and cell therapy
8. The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?
9. Plasmocytes infiltrating autoimmune organs and their putative targeting
10. Biological aging and autoimmunity
11. Efficacy and safety of biologic treatment in autoimmune diseases
12. Nutritional implications for the pathophysiology and treatment of autoimmune disorders
13. Dysbiosis and probiotic applications in autoimmune diseases
14. Precision medicine in managing chronic conditions with an immunological component
15. New advanced therapy medicinal products in treatment of autoimmune diseases
16. Targeting of autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches
17. Immunomodulatory effects of parasites on autoimmunity
18. Prediction of autoimmune diseases: from bench to bedside
2. Innate lymphoid cells as therapeutic targets in autoimmune diseases
3. B regulatory cells in patients with autoimmune diseases: pathogenic significance, therapeutic potential
4. Regulatory T cells in autoimmunity and potential therapeutic targets
5. Application of IL-6 antagonists in autoimmune disorders
6. The search for monomer interaction-based alternative TNF? therapies
7. Generation of thymic cells from pluripotent stem cells for basic research and cell therapy
8. The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?
9. Plasmocytes infiltrating autoimmune organs and their putative targeting
10. Biological aging and autoimmunity
11. Efficacy and safety of biologic treatment in autoimmune diseases
12. Nutritional implications for the pathophysiology and treatment of autoimmune disorders
13. Dysbiosis and probiotic applications in autoimmune diseases
14. Precision medicine in managing chronic conditions with an immunological component
15. New advanced therapy medicinal products in treatment of autoimmune diseases
16. Targeting of autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches
17. Immunomodulatory effects of parasites on autoimmunity
18. Prediction of autoimmune diseases: from bench to bedside